Net Sales up 41% to $3.0 Million in Nine Months Ended December 31, 2025Gross Margin Increased by 46% and Operating Expenses Decreased by ...

Transitioned to a pure-play industrial REIT; Attractive development properties completed; Strong leasing activityTORONTO, March 05, 2026 (GLOBE NEWSWIRE) -- Nexus Industrial REIT (the “REIT”) (TSX: ...

That company that was to provide solar energy to Centre County government agencies pulled out, citing tariffs and an end to federal tax credits.

Samsara Inc. (NYSE: IOT), the pioneer of the Connected Operations® Platform, reported financial results for the fourth quarter and fiscal year ended January 31, 2026, and released a shareholder letter ...

An audit of the Oklahoma Turnpike Authority did not reveal "egregious" wrongdoing or "significant" non-compliance.

The redomiciliation was completed following the close of trading on the Nasdaq Capital Market on March 6, 2026. At completion, all issued and outstanding ordinary shares of Fitell were exchanged on a ...

- 4Q 2025 net income available to common shareholders of $100.2 million, or $2.79 Earnings per Share ("EPS"). Full year 2025 net income available to common shareholders of $406.9 million, or $11.40 ...

Net Sales up 41% to $3.0 Million in Nine Months Ended December 31, 2025 Gross Margin Increased by 46% and Operating Expenses Decreased by 45% Strategic Collaboration with Meta and Global Expansion Acc ...

Units into the sporting goods channel rose 28%, while adjusted NICS declined 2.2%, indicating market share gains. Long gun shipments -- Decreased 25% into the sporting goods channel with adjusted NICS ...

Approval for President Donald Trump’s massive East Wing ballroom project – from a government commission that oversees ...

Good morning, and welcome to the ImmuCell Corporation Conference Call to discuss Unaudited Fourth Quarter and Full Year 2025 Financial Results. [Operator Instructions] Please note, this event is being ...

Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...